Soleno Therapeutics (SLNO) Builds Confidence Amid Outperformance
Soleno Therapeutics (NASDAQ:SLNO) is one of the 17 Biotech Stocks With More Than 50% Up. On January 20, HC Wainwright’s Ram Selvaraju raised his price target on Soleno Therapeutics (NASDAQ:SLNO) from $110 to $120. He also reaffirmed his Buy rating on the stock, which, according to his forecasts, offers a revaluation potential of almost 211%….